1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Mar 12, 2024.
The trade is 27.9% of the 11,941 shares held after it.
4 other insiders bought within 30 days.
27 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Snow Daniel C bought about $10.0K of CPSH on Oct 8, 2025; 4 other insiders bought within 30 days and 27 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 4.2% of the 438,009 shares held after it.
4 other insiders bought within 30 days.
27 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director HUGHES FRANCIS J JR bought about $55.0K of CPSH on Oct 8, 2025, the largest insider purchase at the company on our record; 4 other insiders bought within 30 days and 27 funds added in the latest 13F quarter.
7 earlier Form 4 trades (code P or S) here by this insider (7 buys), the last on Aug 20, 2025.
+15.1% median (+24.1% mean) 90-day return after 5 previous buys.
The trade is 50.8% of the 49,185 shares held after it.
4 other insiders bought within 30 days.
27 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Cavoli Ivo James bought about $75.0K of CPSH on Oct 8, 2025, the largest insider purchase at the company on our record; 4 other insiders bought within 30 days and 27 funds added in the latest 13F quarter.
22 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
No insider has filed to sell. Watch this after a run-up.
CPSH mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Tema Space Innovators ETF
$13.6M position · as of 2026-05-31
0.5%
iShares Micro-Cap ETF
$280.3K position · as of 2026-06-30
0.0%
1290 VT Micro Cap Portfolio
$19.0K position · as of 2026-06-30
0.0%
Avantis U.S. Small Cap Equity ETF
$54.3K position · as of 2026-05-31
0.0%
Fidelity Extended Market Index Fund
$670.9K position · as of 2026-05-31
0.0%
Dimensional U.S. Small Cap ETF
$198.6K position · as of 2026-07-31
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$505.2K
$483.9K
$292.8K
+40%
n/a
2024
$333.4K
$313.8K
$239.7K
-29%
n/a
2023
$710.3K
$354.1K
$300.7K
+3%
n/a
2022
$566.7K
$439.0K
$289.4K
+17%
n/a
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
An activist crossed the 5% line with declared intent.
The record shows 27 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$32.3M
four quarters, 2025-06-29 to 2026-06-27
Revenue, TTM CPSH
FY Dec 2025
$32.6M
FY Dec 2024
$21.1M
FY Dec 2023
$27.6M
FY Dec 2022
$26.6M
FY Dec 2021
$22.4M
Jun 2026
$8.3M
Mar 2026
$7.0M
Dec 2025
$8.2M
Sep 2025
$8.8M
Jun 2025
$8.1M
Mar 2025
$7.5M
Dec 2024
$5.9M
Sep 2024
$4.2M
At each fiscal year end
Single quarter
Net margin, TTM
-0.1%
net income over revenue, 2025-06-29 to 2026-06-27
Net margin, TTM CPSH
FY Dec 2025
+1.3%
FY Dec 2024
n/a
FY Dec 2023
+5.0%
FY Dec 2022
+8.0%
FY Dec 2021
+14.3%
Jun 2026
+0.5%
Mar 2026
-4.2%
Dec 2025
+0.2%
Sep 2025
+2.4%
Jun 2025
+1.3%
Mar 2025
+1.3%
Dec 2024
-16.8%
Sep 2024
-24.6%
At each fiscal year end
Single quarter
Free cash flow, TTM
-$2.8M
operating cash flow minus capex, 2025-06-29 to 2026-06-27
Free cash flow, TTM CPSH
FY Dec 2025
-$487.0K
FY Dec 2024
-$4.5M
FY Dec 2023
$549.2K
FY Dec 2022
$3.1M
FY Dec 2021
$1.5M
Jun 2026
-$2.4M
Mar 2026
-$767.8K
Dec 2025
-$494.4K
Sep 2025
$876.8K
Jun 2025
$476.4K
Mar 2025
-$1.3M
Dec 2024
-$1.5M
Sep 2024
-$1.3M
At each fiscal year end
Single quarter
Debt to equity
0.00x
long-term debt only, 2024-12-28 (18 months older than the period end); equity 2026-06-27
Debt to equity CPSH
FY Dec 2025
0.00x
FY Dec 2024
0.00x
FY Dec 2023
0.00x
FY Dec 2022
0.01x
FY Dec 2021
0.01x
Jun 2026
0.00x
Mar 2026
0.00x
Dec 2025
0.00x
Sep 2025
0.00x
Jun 2025
0.00x
Mar 2025
0.00x
Dec 2024
0.00x
Sep 2024
0.00x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
-206.04x
TTM operating cash flow over long-term debt only, 2024-12-28 (18 months older than the period end)
Cash flow to debt CPSH
FY Dec 2025
29.97x
FY Dec 2024
-427.60x
FY Dec 2023
23.09x
FY Dec 2022
35.99x
FY Dec 2021
10.91x
Jun 2026
-206.04x
Mar 2026
148.14x
Dec 2025
29.97x
Sep 2025
-113.62x
Jun 2025
-388.83x
Mar 2025
-597.54x
Dec 2024
-427.60x
Sep 2024
-94.95x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-0.1%
TTM net income over average of 2025-06-28 and 2026-06-27
Return on equity CPSH
FY Dec 2025
+2.1%
FY Dec 2024
n/a
FY Dec 2023
+8.3%
FY Dec 2022
+14.8%
FY Dec 2021
+32.9%
Jun 2026
-0.1%
Mar 2026
+0.2%
Dec 2025
+2.1%
Sep 2025
-3.8%
Jun 2025
-11.7%
Mar 2025
-18.1%
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-0.1%
TTM net income over average of 2025-06-28 and 2026-06-27
Return on assets CPSH
FY Dec 2025
+1.7%
FY Dec 2024
n/a
FY Dec 2023
+6.3%
FY Dec 2022
+10.5%
FY Dec 2021
+23.7%
Jun 2026
-0.1%
Mar 2026
+0.1%
Dec 2025
+1.7%
Sep 2025
-3.0%
Jun 2025
-9.3%
Mar 2025
-14.3%
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on invested capital CPSH
FY Dec 2025
+1.7%
FY Dec 2024
n/a
FY Dec 2023
+14.9%
FY Dec 2022
+20.9%
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
+1.7%
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
-2.5%
operating income (EBIT proxy) over average of 2025-06-28 and 2026-06-27 minus current liabilities
Return on capital employed CPSH
FY Dec 2025
+2.3%
FY Dec 2024
-27.3%
FY Dec 2023
+10.0%
FY Dec 2022
+14.9%
FY Dec 2021
+5.1%
Jun 2026
-2.5%
Mar 2026
-1.1%
Dec 2025
+2.3%
Sep 2025
-5.0%
Jun 2025
-16.1%
Mar 2025
-24.7%
Dec 2024
-27.3%
Sep 2024
-17.7%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing CPSH
FY Dec 2025
107.00x
FY Dec 2024
n/a
FY Dec 2023
26.11x
FY Dec 2022
17.93x
FY Dec 2021
20.67x
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
107.00x
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$52.5M
market value at close 2026-10-26 on 2026-07-26 shares, plus long-term debt only, 2024-12-28 (18 months older than the period end), minus cash 2026-06-27
Enterprise value CPSH
FY Dec 2025
$53.3M
FY Dec 2024
$20.3M
FY Dec 2023
$25.4M
FY Dec 2022
$30.7M
FY Dec 2021
$57.4M
Jun 2026
$86.9M
Mar 2026
$59.1M
Dec 2025
$53.3M
Sep 2025
$51.4M
Jun 2025
$38.3M
Mar 2025
$21.3M
Dec 2024
$20.3M
Sep 2024
$16.0M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-4.1%
TTM free cash flow over market value at close 2026-10-26
FCF yield CPSH
FY Dec 2025
-0.8%
FY Dec 2024
-19.0%
FY Dec 2023
+1.6%
FY Dec 2022
+8.0%
FY Dec 2021
+2.4%
Jun 2026
-2.7%
Mar 2026
+0.1%
Dec 2025
-0.8%
Sep 2025
-2.7%
Jun 2025
-8.9%
Mar 2025
-24.4%
Dec 2024
-19.0%
Sep 2024
-14.3%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing CPSH
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
0.10x
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
CPSH ranks highest on growth (94th percentile) and financial health (48th), and lowest on risk and compliance (14th), among Materials peers.
Profitability
40
Inputs
Return on equity-0.1% · 41 pct, sector of 100
Return on assets-0.1% · 47 pct, sector of 120
Return on invested capitalpre-tax loss, no effective tax rate to apply
Return on capital employed-2.5% · 31 pct, sector of 96
Financial health
48
Inputs
Debt to equity0.00x · 95 pct, sector of 104
Cash flow to debt-206.04x · 0 pct, sector of 103
Growth
94
Inputs
Revenue growth, YoY+54.3% · 94 pct, sector of 128
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
16
Inputs
Funds adding, latest quarter27 · 16 pct, sector of 118
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
14
Inputs
Short interest, % of float+8.1% · 27 pct, sector of 145
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-K+89.4% · 1 pct, sector of 111
2 not measured: Insider conviction, US patents
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CPSH filings, in plain words
Read the full summary
1 activist Schedule 13D filing in the last 180 days declared an intent to influence the company, the largest for 6.5% of the class. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.